FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint.
FDA Official Says Acceptance of PFS “Brings Us In Line With Our European Colleagues.”
NCI Says Sponsored Meetings Must Be Held In Smoke-Free Localities As of Jan. 1.
